Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
P Gutiérrez-Castrellón, T Gandara-Martí… - Gut …, 2022 - Taylor & Francis
Intestinal bacteria may influence lung homeostasis via the gut-lung axis. We conducted a
single-center, quadruple-blinded, randomized trial in adult symptomatic Coronavirus …
single-center, quadruple-blinded, randomized trial in adult symptomatic Coronavirus …
Probiotics use is associated with improved clinical outcomes among hospitalized patients with COVID-19
Background and aims: Currently, there are no definitive therapies for coronavirus disease
2019 (COVID-19). Gut microbial dysbiosis has been proved to be associated with COVID-19 …
2019 (COVID-19). Gut microbial dysbiosis has been proved to be associated with COVID-19 …
[HTML][HTML] Oral probiotics in coronavirus disease 2019: Connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials
Defined as helpful live bacteria that can provide medical advantages to the host when
administered in tolerable amounts, oral probiotics might be worth considering as a possible …
administered in tolerable amounts, oral probiotics might be worth considering as a possible …
Probiotics as adjunctive treatment for patients contracted COVID-19: current understanding and future needs
The coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which rages all over the world and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), which rages all over the world and …
Probiotics in prevention and treatment of COVID-19: current perspective and future prospects
Saving lives and flattening the curve are the foremost priorities during the ongoing pandemic
spread of SARS-CoV-2. Developing cutting-edge technology and collating available …
spread of SARS-CoV-2. Developing cutting-edge technology and collating available …
Probiotics and COVID‐19: is there any link?
A Akour - Letters in applied microbiology, 2020 - academic.oup.com
Understanding mechanisms of the novel SARS‐CoV2 infection and progression can provide
potential novel targets for prevention and/or treatment. This could be achieved via the …
potential novel targets for prevention and/or treatment. This could be achieved via the …
Probiotics in the prophylaxis of COVID-19: something is better than nothing
The new viral pandemic of COVID-19 is caused by a novel coronavirus (SARS-CoV-2) that
has brought the world at another unprecedented crisis in terms of health and economy. The …
has brought the world at another unprecedented crisis in terms of health and economy. The …
Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?
KS Batista, JG de Albuquerque… - Nutrition research …, 2023 - cambridge.org
Scientists are working to identify prevention/treatment methods and clinical outcomes of
coronavirus disease 2019 (COVID-19). Nutritional status and diet have a major impact on …
coronavirus disease 2019 (COVID-19). Nutritional status and diet have a major impact on …
Gut dysbiosis during COVID-19 and potential effect of probiotics
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an RNA virus of the family
Coronaviridae, causes coronavirus disease 2019 (COVID-19), an influenza-like disease that …
Coronaviridae, causes coronavirus disease 2019 (COVID-19), an influenza-like disease that …
Targeting microbiome: an alternative strategy for fighting SARS-CoV-2 infection
O Spagnolello, C Pinacchio, L Santinelli, P Vassalini… - Chemotherapy, 2021 - karger.com
Respiratory and gastrointestinal symptoms are the predominant clinical manifestations of the
coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute …
coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute …